There is mounting evidence to support a role for developmentally regulated epigenetic variation in the molecular etiology of neuropsychiatric and neurodegenerative disorders. In this talk I will present on-going work from our group aimed at identifying epigenetic variation associated with a diverse range of neuropsychiatric phenotypes including schizophrenia, autism and dementia.
[more]
